CV Sciences is a life science company that focuses on developing and commercializing novel cannabidiol‐based medicines.Read more
CV Sciences's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 64.7M. Over the last four quarters, CV Sciences's revenue has decreased by 19%. Specifically, in Q2 2022's revenue was $4.1M; in Q1 2022, it was $4.4M; in Q4 2021, it was $5M; in Q3 2021, CV Sciences's revenue was $5.1M.